☰

Yan Du, Ph.D. - Publications

Affiliations: 
2011 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Public Health, Behavioral, Genetics, Oncology, Epidemiology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Deng Y, Wang J, Wang L, Du Y. Androgen receptor gene CAG repeat polymorphism and ovarian cancer risk: A meta-analysis. Bioscience Trends. PMID 28250337 DOI: 10.5582/Bst.2016.01229  0.3
2016 Du Y, Han X, Ding YB, Yin JH, Cao GW. Prediction and prophylaxis of hepatocellular carcinoma occurrence and postoperative recurrence in chronic hepatitis B virus-infected subjects. World Journal of Gastroenterology. 22: 6565-72. PMID 27547000 DOI: 10.3748/Wjg.V22.I29.6565  0.302
2016 Liu WB, Wu JF, Du Y, Cao GW. Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis. Current Oncology (Toronto, Ont.). 23: e49-56. PMID 26966413 DOI: 10.3747/Co.23.2836  0.315
2015 Xu X, Chang W, Yuan J, Han X, Tan X, Ding Y, Luo Y, Cai H, Liu Y, Gao X, Liu Q, Yu Y, Du Y, Wang H, Ma L, et al. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche. Oncotarget. PMID 26556874 DOI: 10.18632/Oncotarget.5985  0.311
2015 Yin J, Wang J, Pu R, Xin H, Li Z, Han X, Ding Y, Du Y, Liu W, Deng Y, Ji X, Wu M, Yu M, Zhang H, Wang HY, et al. Hepatitis B virus combo mutations improve the prediction and active prophylaxis of hepatocellular carcinoma: a clinic-based cohort study. Cancer Prevention Research (Philadelphia, Pa.). PMID 26290395 DOI: 10.1158/1940-6207.Capr-15-0160  0.302
2014 Ji X, Zhang Q, Du Y, Liu W, Li Z, Hou X, Cao G. Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma. Current Genomics. 15: 469-80. PMID 25646075 DOI: 10.2174/1389202915666141114213833  0.304
2014 Du Y, Han X, Pu R, Xie J, Zhang Y, Cao G. Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Frontiers of Medicine. 8: 217-26. PMID 24748463 DOI: 10.1007/S11684-014-0326-2  0.302
2014 Yu Z, Zhang C, Chai R, Du Y, Gao X, Xing J, Yu E, Zhang W, Zhang X, Cao G, Fu C. Prognostic significance and molecular mechanism of ATP-binding cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinoma. Plos One. 9: e85446. PMID 24454870 DOI: 10.1371/Journal.Pone.0085446  0.312
2013 Yu Z, Zhang C, Chai R, Du Y, Gao X, Xing J, Cao G, Fu C. Abstract C217: Prognostic significance and molecular mechanism of ATP-Binding Cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinoma. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-C217  0.318
2012 Chen L, Zhang Q, Chang W, Du Y, Zhang H, Cao G. Viral and host inflammation-related factors that can predict the prognosis of hepatocellular carcinoma European Journal of Cancer. 48: 1977-1987. PMID 22325840 DOI: 10.1016/J.Ejca.2012.01.015  0.312
2010 Mutetwa B, Fryzek J, Du Y, Yong M, Sekeres MA, Taioli E. Predictors of Outcome In Patients with Myelodysplastic Syndromes Living In Western Pennsylvania Blood. 116: 4971-4971. DOI: 10.1182/Blood.V116.21.4971.4971  0.307
Show low-probability matches.